Alberti Adriano, Schuelter-Trevisol Fabiana, Iser Betine Pinto Moehlecke, Traebert Eliane, Freiberger Viviane, Ventura Leticia, Rezin Gislaine Tezza, da Silva Bruna Becker, Meneghetti Dallacosta Fabiana, Grigollo Leoberto, Dias Paula, Fin Gracielle, De Jesus Josiane Aparecida, Pertille Fabiane, Rossoni Carina, Hur Soares Ben, Nodari Júnior Rudy José, Comim Clarissa Martinelli
Research Group in Neurodevelopment of Childhood and Adolescence, Laboratory of Experimental Neuroscience, Postgraduate Program in Health Sciences, University of South Santa Catarina (Unisul), Palhoça, 88137-270, Santa Catarina, Brazil.
Brazil Clinical Research Center, Postgraduate Program in Health Sciences, University of Southern Santa Catarina at Tubarão, Tubarão, 88704 -900, Santa Catarina, Brazil.
World J Clin Cases. 2021 Jul 16;9(20):5358-5371. doi: 10.12998/wjcc.v9.i20.5358.
At the end of 2019, a new disease with pandemic potential appeared in China. It was a novel coronavirus called coronavirus disease 2019 (COVID-19). Later, in the first quarter of 2020, the World Health Organization declared the outbreak of this disease a pandemic. Elderly people, people with comorbidities, and health care professionals are more vulnerable to COVID-19. Obesity has been growing exponentially worldwide, affecting several age groups. It is a morbidity that is associated with genetic, epigenetic, environment factors and/or interaction between them. Obesity is associated with the development of several diseases including diabetes mellitus, mainly type 2. Diabetes affects a significant portion of the global population. Obesity and diabetes are among the main risk factors for the development of severe symptoms of COVID-19, and individuals with these conditions constitute a risk group. Based on a literature review on obesity in people with diabetes in the framework of the COVID-19 pandemic, this study presents updated important considerations and care to be taken with this population.
2019年底，一种具有大流行潜力的新疾病在中国出现。它是一种名为2019冠状病毒病（COVID-19）的新型冠状病毒。后来，在2020年第一季度，世界卫生组织宣布这种疾病的爆发为大流行。老年人、患有合并症的人以及医护人员更容易感染COVID-19。肥胖在全球呈指数级增长，影响多个年龄组。它是一种与遗传、表观遗传、环境因素和/或它们之间的相互作用相关的发病率。肥胖与包括糖尿病（主要是2型糖尿病）在内的几种疾病的发生有关。糖尿病影响着全球很大一部分人口。肥胖和糖尿病是COVID-19出现严重症状的主要危险因素之一，患有这些疾病的个体构成一个风险群体。基于对COVID-19大流行背景下糖尿病患者肥胖问题的文献综述，本研究提出了针对这一人群的最新重要注意事项和护理措施。
Zotero 插件